BioLife Solutions, Inc. – NASDAQ:BLFS

BioLife Solutions stock price today

$24.52
-2.07
-7.78%
Financial Health
0
1
2
3
4
5
6
7
8
9

BioLife Solutions stock price monthly change

+28.33%
month

BioLife Solutions stock price quarterly change

+28.33%
quarter

BioLife Solutions stock price yearly change

+57.71%
year

BioLife Solutions key metrics

Market Cap
1.23B
Enterprise value
N/A
P/E
-5.9
EV/Sales
N/A
EV/EBITDA
N/A
Price/Sales
5.13
Price/Book
2.28
PEG ratio
N/A
EPS
-1.42
Revenue
137.29M
EBITDA
-44.51M
Income
-62.93M
Revenue Q/Q
-15.85%
Revenue Y/Y
-15.89%
Profit margin
-85.79%
Oper. margin
-89.37%
Gross margin
33.27%
EBIT margin
-89.37%
EBITDA margin
-32.42%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

BioLife Solutions stock price history

BioLife Solutions stock forecast

BioLife Solutions financial statements

Average Price Target
Last Year

$30

Potential upside: 22.34%

Based on estimate of 2 analysts
  • Analysts Price target

  • Financials & Ratios estimates

BioLife Solutions, Inc. (NASDAQ:BLFS): Profit margin
Jun 2023 39.50M -10.19M -25.82%
Sep 2023 33.32M -29.13M -87.41%
Dec 2023 32.73M -13.38M -40.89%
Mar 2024 31.72M -10.22M -32.22%
BioLife Solutions, Inc. (NASDAQ:BLFS): Debt to assets
Jun 2023 433177000 81.04M 18.71%
Sep 2023 411152000 79.13M 19.25%
Dec 2023 412714000 75.05M 18.18%
Mar 2024 401602000 68.19M 16.98%
BioLife Solutions, Inc. (NASDAQ:BLFS): Cash Flow
Jun 2023 -7.71M 9.29M 704K
Sep 2023 -4.37M 1.66M 608K
Dec 2023 2.31M 3.95M 9.84M
Mar 2024 -4.47M -221K -952K

BioLife Solutions alternative data

BioLife Solutions, Inc. (NASDAQ:BLFS): Employee count
Aug 2023 466
Sep 2023 466
Oct 2023 466
Nov 2023 466
Dec 2023 466
Jan 2024 466
Feb 2024 466
Mar 2024 409
Apr 2024 409
May 2024 409
Jun 2024 409
Jul 2024 409

BioLife Solutions other data

81.14% +0.27%
of BLFS is owned by hedge funds
35.13M +118.84K
shares is hold by hedge funds

BioLife Solutions, Inc. (NASDAQ:BLFS): Insider trades (number of shares)
Period Buy Sel
Jan 2024 0 13704
Feb 2024 0 585
Mar 2024 0 56215
Apr 2024 0 17111
May 2024 0 12617
Jun 2024 0 10000
Jul 2024 0 5155
Aug 2024 0 495
Sep 2024 0 24887
Oct 2024 0 22232
Nov 2024 0 44952
Dec 2024 0 20800
Transaction Date Insider Security Shares Price per share Total value Source
Sale
MATHEW ABY J. officer: EVP & Ch.. Common Stock 13,196 $27.16 $358,403
Sale
MATHEW ABY J. officer: EVP & Ch.. Common Stock 7,604 $27.33 $207,817
Sale
WICHTERMAN TROY officer: Chief Financial Officer
Common Stock 581 $27.2 $15,803
Sale
MATHEW ABY J. officer: EVP & Ch.. Common Stock 523 $27.2 $14,226
Sale
BERARD TODD officer: Chief Ma.. Common Stock 349 $27.2 $9,493
Sale
AEBERSOLD SARAH officer: Chief Human Resources ..
Common Stock 216 $27.2 $5,875
Sale
FOSTER KAREN A. officer: Chief Qu.. Common Stock 252 $27.2 $6,854
Sale
MATHEW ABY J. officer: EVP & Ch.. Common Stock 17,604 $20.05 $352,960
Option
MATHEW ABY J. officer: EVP & Ch.. Common Stock 10,000 $2.06 $20,600
Sale
MATHEW ABY J. officer: EVP & Ch.. Common Stock 10,000 $21.16 $211,600
Patent
Application
Filling date: 2 Oct 2019 Issue date: 27 Jan 2022
Application
Filling date: 8 Apr 2020 Issue date: 14 Oct 2021
Application
Filling date: 8 Apr 2020 Issue date: 14 Oct 2021
Application
Filling date: 5 Jan 2021 Issue date: 22 Jul 2021
Application
Filling date: 11 Apr 2019 Issue date: 13 May 2021
Grant
Filling date: 23 May 2017 Issue date: 9 Feb 2021
Grant
Filling date: 16 Jan 2018 Issue date: 4 Aug 2020
Grant
Filling date: 14 May 2015 Issue date: 4 Feb 2020
Grant
Filling date: 3 Jun 2014 Issue date: 14 Jan 2020
Application
Filling date: 31 May 2019 Issue date: 5 Dec 2019
Monday, 16 December 2024
prnewswire.com
Thursday, 14 November 2024
prnewswire.com
Tuesday, 12 November 2024
seekingalpha.com
zacks.com
prnewswire.com
prnewswire.com
Thursday, 31 October 2024
prnewswire.com
Monday, 21 October 2024
zacks.com
Monday, 7 October 2024
zacks.com
Tuesday, 17 September 2024
zacks.com
Tuesday, 20 August 2024
seekingalpha.com
Friday, 9 August 2024
seekingalpha.com
Thursday, 8 August 2024
zacks.com
prnewswire.com
Thursday, 25 July 2024
prnewswire.com
Friday, 12 July 2024
zacks.com
Friday, 31 May 2024
zacks.com
Wednesday, 29 May 2024
prnewswire.com
Thursday, 9 May 2024
Seeking Alpha
Zacks Investment Research
Monday, 4 March 2024
PRNewsWire
Thursday, 29 February 2024
Seeking Alpha
Wednesday, 29 November 2023
Seeking Alpha
Thursday, 9 November 2023
Seeking Alpha
Monday, 9 October 2023
Zacks Investment Research
Wednesday, 13 September 2023
Zacks Investment Research
Friday, 11 August 2023
The Motley Fool
Wednesday, 9 August 2023
The Motley Fool
Tuesday, 8 August 2023
Zacks Investment Research
GuruFocus
  • What's the price of BioLife Solutions stock today?

    One share of BioLife Solutions stock can currently be purchased for approximately $24.52.

  • When is BioLife Solutions's next earnings date?

    Unfortunately, BioLife Solutions's (BLFS) next earnings date is currently unknown.

  • Does BioLife Solutions pay dividends?

    No, BioLife Solutions does not pay dividends.

  • How much money does BioLife Solutions make?

    BioLife Solutions has a market capitalization of 1.23B and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 11.43% to 143.27M US dollars.

  • What is BioLife Solutions's stock symbol?

    BioLife Solutions, Inc. is traded on the NASDAQ under the ticker symbol "BLFS".

  • What is BioLife Solutions's primary industry?

    Company operates in the Healthcare sector and Medical - Instruments & Supplies industry.

  • How do i buy shares of BioLife Solutions?

    Shares of BioLife Solutions can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are BioLife Solutions's key executives?

    BioLife Solutions's management team includes the following people:

    • Mr. Michael P. Rice Chairman & Chief Executive Officer(age: 62, pay: $514,710)
    • Dr. Aby J. Mathew Chairman of Scientific Advisory Board, Executive Vice President & Chief Scientific Officer(age: 53, pay: $407,640)
    • Mr. Roderick de Greef Pres & Chief Operating Officer(age: 65, pay: $390,890)
    • Ms. Karen Foster Chief Quality Officer(age: 65, pay: $345,730)
    • Mr. Todd Berard Chief Marketing Officer(age: 56, pay: $286,490)
  • How many employees does BioLife Solutions have?

    As Jul 2024, BioLife Solutions employs 409 workers.

  • When BioLife Solutions went public?

    BioLife Solutions, Inc. is publicly traded company for more then 35 years since IPO on 22 Nov 1989.

  • What is BioLife Solutions's official website?

    The official website for BioLife Solutions is biolifesolutions.com.

  • Where are BioLife Solutions's headquarters?

    BioLife Solutions is headquartered at 3303 Monte Villa Parkway, Bothell, WA.

  • How can i contact BioLife Solutions?

    BioLife Solutions's mailing address is 3303 Monte Villa Parkway, Bothell, WA and company can be reached via phone at 425 402 1400.

  • What is BioLife Solutions stock forecast & price target?

    Based on 2 Wall Street analysts` predicted price targets for BioLife Solutions in the last 12 months, the avarage price target is $30. The average price target represents a 22.34% change from the last price of $24.52.

BioLife Solutions company profile:

BioLife Solutions, Inc.

biolifesolutions.com
Exchange:

NASDAQ

Full time employees:

409

Industry:

Medical - Instruments & Supplies

Sector:

Healthcare

BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; and the ThawSTAR line that includes automated vial and cryobag thawing products that control the heat and timing of the thawing process of biologic materials. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage services. It markets and sells its products directly, as well as through third party distributors. BioLife Solutions, Inc. was incorporated in 1987 and is headquartered in Bothell, Washington.

3303 Monte Villa Parkway
Bothell, WA 98021

CIK: 0000834365
ISIN: US09062W2044
CUSIP: 09062W204